Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01843283 · ClinicalTrials.gov registry record · Phase 1
Meaningful Activity Intervention for Persons With Mild Cognitive Impairment
A Phase 1 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT01843283 is a Phase 1 study that has completed, run by Indiana University. The registered enrollment target is 80 participants.
The verdict
NCT01843283, a Phase 1 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate the feasibility of and satisfaction with the revised DEMA and to estimate effect sizes for DEMA through incorporation of a comparison group. Specific aims are as follows: Aim 1: Evaluate feasibility of the study for MCI patient/caregivers. Aim 2: Estimate effect sizes for DEMA on MCI patient and caregiver outcomes. Aim 3: Evaluate MCI patients and family caregivers' satisfaction with and perceptions of DEMA or IS.
Interventions
- BEHAVIORAL Daily Enhancement Meaningful Activity (DEMA)
- BEHAVIORAL Information Support (IS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2012-07 |
| Est. Completion | 2016-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01843283
The ClinicalTrials.gov registry entry for NCT01843283 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Daily Enhancement Meaningful Activity (DEMA) is the first listed.
NCT01843283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01843283 about?
NCT01843283 is a clinical study titled "Meaningful Activity Intervention for Persons With Mild Cognitive Impairment". The purpose of this pilot study is to evaluate the feasibility of and satisfaction with the revised DEMA and to estimate effect sizes for DEMA through incorporation of a comparison group. Specific aims are as follows: Aim 1: Evaluate feasibility of the study for MCI patient/caregivers. Aim 2: Estim...
What is the current status of trial NCT01843283?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2012-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01843283?
The interventions under investigation include: Daily Enhancement Meaningful Activity (DEMA) (BEHAVIORAL), Information Support (IS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01843283?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.